A cross-sectional study was conducted to assess pulmonary function in adults diagnosed with Type 2 diabetes. Participants were categorized into two groups based on body mass index (BMI): those with obesity (BMI = 30 kg/m²) and those without obesity (BMI < 30 kg/m²). Standardized pulmonary function tests, including spirometry and lung volume measurements, were employed to evaluate respiratory parameters. Demographic and clinical data, including diabetes duration and glycemic control, were also collected. The analysis included adults with Type 2 diabetes, with classified as obese. Comparative analysis revealed that individuals with obesity exhibited a significant reduction in various pulmonary function parameters compared to their non-obese counterparts. Specifically, forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and total lung capacity (TLC) were consistently lower in the obese group. These differences remained significant even after adjusting for potential confounding factors.
Understanding the relationship between Type 2 diabetes, obesity, and impaired pulmonary function has clinical implications for healthcare providers. Routine monitoring of respiratory parameters should be integrated into the comprehensive care of individuals with Type 2 diabetes, with targeted interventions for those with obesity to mitigate the risk of respiratory complications. In conclusion, this study underscores the impact of obesity on pulmonary function in adults with Type 2 diabetes. The findings highlight the need for a holistic approach to diabetes management that includes regular assessment of respiratory health, particularly in individuals with obesity. Early recognition and targeted interventions can play a pivotal role in preserving pulmonary function and improving the overall well-being of individuals with Type 2 diabetes.
